Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP1004009.RAosc-6PmvSdV1niYPDV-m51_9yZ9CZ9R6-Plk-UvsCy8130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP1004009.RAosc-6PmvSdV1niYPDV-m51_9yZ9CZ9R6-Plk-UvsCy8130_assertion type Assertion NP1004009.RAosc-6PmvSdV1niYPDV-m51_9yZ9CZ9R6-Plk-UvsCy8130_head.
- NP1004009.RAosc-6PmvSdV1niYPDV-m51_9yZ9CZ9R6-Plk-UvsCy8130_assertion description "[As seen in this case, most breast cancers in patients with LFS exhibit a triple-positive phenotype (estrogen receptor-positive/progesterone receptor-positive/HER2-positive).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1004009.RAosc-6PmvSdV1niYPDV-m51_9yZ9CZ9R6-Plk-UvsCy8130_provenance.
- NP1004009.RAosc-6PmvSdV1niYPDV-m51_9yZ9CZ9R6-Plk-UvsCy8130_assertion evidence source_evidence_literature NP1004009.RAosc-6PmvSdV1niYPDV-m51_9yZ9CZ9R6-Plk-UvsCy8130_provenance.
- NP1004009.RAosc-6PmvSdV1niYPDV-m51_9yZ9CZ9R6-Plk-UvsCy8130_assertion SIO_000772 22878818 NP1004009.RAosc-6PmvSdV1niYPDV-m51_9yZ9CZ9R6-Plk-UvsCy8130_provenance.
- NP1004009.RAosc-6PmvSdV1niYPDV-m51_9yZ9CZ9R6-Plk-UvsCy8130_assertion wasDerivedFrom befree-2016 NP1004009.RAosc-6PmvSdV1niYPDV-m51_9yZ9CZ9R6-Plk-UvsCy8130_provenance.
- NP1004009.RAosc-6PmvSdV1niYPDV-m51_9yZ9CZ9R6-Plk-UvsCy8130_assertion wasGeneratedBy ECO_0000203 NP1004009.RAosc-6PmvSdV1niYPDV-m51_9yZ9CZ9R6-Plk-UvsCy8130_provenance.